FDA, Meta Executives Recruited for Precision Neuroscience’s Management Team

Precision Neuroscience Corporation has welcomed two new senior executives to its leadership team, hiring Vanessa Tolosa, Ph.D., as senior vice president of Research and Development; and Vivek Pinto, Ph.D., as Medical Affairs director.

Dr. Tolosa, an expert in microfabricated neural implants, is widely recognized for her work developing biocompatible, high-resolution neural interfaces. She began her career at Lawrence Livermore National Laboratory, where she led early work on flexible, polymer-based electrode arrays. As a co-founder of Neuralink, Dr. Tolosa served as director of Neural Interfaces and led the company’s microfabrication efforts, including electrode development, packaging, and cleanroom operations. Most recently, she was a hardware research manager at Meta’s Reality Labs, where she spearheaded the development of next-generation EMG-based wearables.

“I’ve spent my career designing neural interfaces at the edge of what’s possible,” Dr. Tolosa said. “Precision brings together technical ambition, clinical insight, and real-world focus. The team isn’t just building a device—they’re rethinking the entire concept of a BCI, including how it’s delivered surgically, which is essential for patient adoption. I’m honored to help bring this technology to people who need it.”

Dr. Pinto, a former division director at the U.S. Food and Drug Administration’s (FDA) Center for Devices and Radiological Health (CDRH), has more than two decades of experience in product development, clinical research, and regulatory leadership. During his 12-year tenure at the FDA, Dr. Pinto rose from lead scientific reviewer to branch chief and ultimately division director, where he supervised four teams responsible for the regulation of therapeutic and assistive devices across neuromodulation, physical medicine, and neuropsychiatry. At Precision, he will lead medical affairs, helping bridge clinical evidence generation, effective medical communication, and patient adoption.

“This role taps into everything I care about—collaboration, education, and advancing technologies that make a difference for patients and clinicians,” Dr. Pinto stated. “What drew me to Precision was the clarity of purpose: a focus on building something that’s innovative, feasible, and grounded in what patients and clinicians actually need. It’s a rare opportunity to help shape where the field is headed.”

Precision’s momentum continues to build following a series of technical and clinical milestones. Earlier this year, the company received FDA 510(k) clearance for its Layer 7 Cortical Interface, enabling longer-term implants of its devices. “We are thrilled about these hires,” Precision Co-Founder/CEO Michael Mager commented. “Vanessa is one of the most respected engineers working in neural implants today. Her expertise spans advanced materials, manufacturing, and system integration—skills that are critical as we scale toward production. And with Vivek, we now have a senior medical leader who brings firsthand insight into how groundbreaking devices move from concept to clinical adoption. Together, they position us to make decisive progress toward our first clinical applications.”

Precision Neuroscience is developing treatments for neurological illnesses. The company is building the only brain–computer interface designed to be minimally invasive, safely removable, and capable of processing large data sets.